Form 8-K - Current report:
SEC Accession No. 0000950170-24-114315
Filing Date
2024-10-11
Accepted
2024-10-11 16:05:07
Documents
13
Period of Report
2024-10-11
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcon-20241011.htm   iXBRL 8-K 56755
2 EX-3.1 tcon-ex3_1.htm EX-3.1 21165
3 EX-3.2 tcon-ex3_2.htm EX-3.2 8737
  Complete submission text file 0000950170-24-114315.txt   210547

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tcon-20241011.xsd EX-101.SCH 24870
16 EXTRACTED XBRL INSTANCE DOCUMENT tcon-20241011_htm.xml XML 4729
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

EIN.: 342037594 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36818 | Film No.: 241367577
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)